Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. NVNO
NVNO logo

NVNO Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy enVVeno Medical Corp (NVNO) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
11.550
1 Day change
4.81%
52 Week Range
196.700
Analysis Updated At
2026/07/03
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

NVNO is not a good buy right now for a Beginner long-term investor with $50,000-$100,000 who wants a clear immediate decision. The technical setup is mildly constructive, but there is no strong catalyst, no recent news support, no analyst-upgrade momentum, and no Intellectia proprietary buy signal. My direct view: hold off for now rather than buy immediately.

Technical Analysis

NVNO closed at 11.11, exactly unchanged from the previous close, with the broader market also slightly weak. The MACD histogram is positive at 0.0851 and expanding, which supports short-term bullish momentum. RSI_6 at 59.964 is neutral-to-bullish, not overbought. Moving averages are converging, suggesting the stock is still searching for direction rather than in a strong trend. Key levels matter here: pivot 10.772 is close below current price, with resistance at 11.539 and 12.014. That means upside exists, but the stock has not yet broken out decisively. Near-term modeled trend is weak-to-mixed, with only modest probability of gains over the next week and month.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

The options data is sparse, but the reported put-call ratios are 0.0, which does not provide a meaningful bearish signal and can also indicate limited options activity. Historical volatility is 62.49, showing the stock can move sharply, but there is no accompanying open interest or volume confirmation to suggest strong directional sentiment. Overall, options data is neutral and not supportive of an aggressive buy.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
3
Buy
7

Positive Catalysts

  • ["MACD histogram is positive and expanding, showing improving momentum.", "RSI is neutral-bullish, so the stock is not stretched technically.", "Price is trading above the pivot level, which keeps the short-term structure intact.", "No recent negative news was reported during the last week."]

Neutral/Negative Catalysts

  • ["No news in the recent week, so there is no fresh event-driven catalyst.", "No recent analyst upgrades or price target increases were provided.", "Hedge funds are neutral with no significant trading trends in the last quarter.", "Insiders are neutral with no significant trading trends in the last month.", "No recent congress trading data is available.", "No Intellectia AI Stock Picker signal today and no recent SwingMax signal."]

Financial Performance

No usable financial snapshot was provided because of a data error, so there is no latest-quarter revenue or earnings growth readout to support a long-term buy thesis. Because the latest quarter season and financial growth metrics are unavailable, there is not enough fundamental evidence here for a Beginner investor to justify a large immediate allocation.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target change data was provided, so there is no evidence of improving Wall Street sentiment. Based on the available information, Wall Street appears neutral rather than bullish: there are no recent upgrades, no target hikes, and no clear pros outweighing the cons. The main pros are mild technical improvement and the absence of negative news; the cons are weak institutional/insider interest, no catalyst, and no supportive analyst momentum.

Wall Street analysts forecast NVNO stock price to rise
Analyst Rating
0
Wall Street analysts forecast NVNO stock price to rise
Buy
Hold
Sell
0
Current: 11.020
sliders
Low
0
Averages
0
High
0
0
Current: 11.020
sliders
Low
0
Averages
0
High
0
Ladenburg
Neutral -> Buy
upgrade
$30
AI Analysis
2026-07-06
New
Reason
Ladenburg
Price Target
$30
AI Analysis
2026-07-06
New
upgrade
Neutral -> Buy
Reason
Ladenburg upgraded enVVeno Medical to Buy from Neutral with a $30 price target.

People Also Watch